Sujata Singh

Hexamerization of Anti-SARS CoV IgG1 Antibodies Improves Neutralization Capacity

Laura J. Kingsley, D. Grandy, A. Cheng, 2022, Frontiers in Immunology.

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

A. Korman, R. T. Bunch, M. Selby, 2014, Cancer Immunology Research.

Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variants

A. Cheng, S. Hollingsworth, M. Bailly, 2023, Scientific reports.

In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates

A. Korman, M. Selby, Susan Wong, 2014, Cancer Immunology Research.